Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/

RxCapital

Longitude Capital

Medicxi

Bain Capital Life Sciences

BB Biotech Ventures

RA Capital Management

Rivus Pharmaceuticals 

We're developing a new class of investigational medicines that target energy consumption instead of energy intake, resulting in fat-specific weight-loss. Our CEO, Dr. Jayson Dallas, shares with PharmaVoice how our unique therapeutic approach stands out amidst a crowded landscape and how we are aiming to go beyond obesity to treat cardiometabolic diseases. Read more: https://bit.ly/3IUnp1T 

Arrakis Therapeutics is a biopharmaceutical company focused on developing RNA-targeted small molecule drugs for the treatment of various diseases.

Arrakis Therapeutics

MyoKardia is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of serious cardiovascular diseases.

MyoKardia

Portola Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of thrombosis and other hematologic conditions.

Portola Pharma

Cellino is a biotechnology company focused on developing innovative cell therapies for the treatment of various diseases.

Cellino

Tenaya Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease.

Tenaya Therapeutics

Applied Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel treatments for metabolic diseases.

Applied Therapeutics

Aria Pharmaceuticals is a biopharmaceutical company focused on developing therapies for rare and orphan diseases.

Aria Pharmaceuticals

Ardelyx is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for kidney and cardiovascular diseases.

Ardelyx

MRM Health is a biotechnology company focused on developing novel treatments for infectious diseases and immune disorders.

MRM Health

OrsoBio is a biopharmaceutical company focused on developing innovative therapies for rare genetic diseases.

OrsoBio

Rivus Pharmaceuticals is a biotechnology company focused on developing innovative therapies for the treatment of rare and infectious diseases.

Chief Executive Officer

Member Board of Directors

Executive Chairman

Member Board Of Directors

President and CEO

Chief Executive Officer at Rivus Pharmaceuticals

Jayson Dallas

Rivus Pharmaceuticals

Executive Business Partner

Senior Executive Assistant

Chief of Staff

Global Program Manager

Senior Administrative Assistant

Administrative Assistant

Executive Business Partner at Rivus

Brittany Chmielewski

Chief Operating Officer, Rivus Pharmaceuticals, Inc.

Allen Cunningham

Senior Director & Controller

Biotech and Pharmaceutical Accounting Consultant

Vice President, Finance And Administration

Senior Director Finance Capital Projects & Corporate Affairs (NASDAQ-FOLD)

Vice President Of Finance And Operations

Corporate Controller

Assistant Controller

Biotech and Pharmaceutical Finance & Accounting Professional

Mariam Faragalla

Director, IP

Licensing Associate

Research Instructor

Postdoctoral Fellow

Graduate Student

IP protection and Business Development

Mikael Herlevsen

Director of Development

Senior Scientist

Post-Doctoral fellow

Post-Doctoral Fellow

Jameel Dennis

Chief Medical Officer

Consultant

Head of Therapeutics

Senior Research Physician

Chief Medical Officer @ Rivus Pharmaceuticals | MD, MPH

Robert Schott

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 2, 2024 9:28 PM	c0f566cc
public peers	general	May 2, 2024 9:28 PM	8df29b93
news daily refresh	general	Sep 1, 2024 12:10 PM	19a1cdd1
news processing daily refresh	general	Sep 2, 2024 9:54 AM	161a25fe
news impact assignment daily	general	Sep 3, 2024 9:50 AM	08d09f50
news processing basic	general	May 2, 2024 9:28 PM	07ff85dc
company summary	general	Aug 24, 2024 11:40 AM	803a9c12
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	43530399
crunchbase profile	general
li profile	general	May 2, 2024 9:28 PM	d0346998
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 2, 2024 9:28 PM	264d7c6f
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:RIVUSPHARMA

Rivus Pharmaceuticals